Clinical Trial Update: Prospective Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of PBS/Interstitial Cystitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intravesical chondroitin sulfate 2% and DMSO for painful bladder syndrome/interstitial cystitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis
• Painful Bladder Syndrome

Drugs mentioned

• DMSO (dimethyl sulfoxide)
• intravesical chondroitin sulfate 2% (chondroitin sulfate)

Snippet

Sponsor: National Multiple Sclerosis Center | Conditions: Painful Bladder Syndrome, Interstitial Cystitis | Phase 4 | Status: TERMINATED